Odence-Ford Marion has filed 52 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 4000 shares of OptimizeRx Corp ($OPRX) on February 11, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | M | Common Stock | 4000 | $0.00 | 93,322.0000 | 20,333,839 | 4.48% | 0.02% |
| Feb. 11, 2026 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | F | Common Stock | 1386 | $9.23 | 91,936.0000 | 20,333,839 | 1.49% | 0.01% |
| Feb. 11, 2026 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | M | Restricted Stock Units | 4000 | $0.00 | 0.0000 | 20,333,839 | 100.00% | 0.02% |
| Dec. 23, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | F | Common Stock | 4051 | $12.74 | 89,322.0000 | 20,333,839 | 4.34% | 0.02% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | M | Restricted Stock Units | 3928 | $0.00 | 3,928.0000 | 20,333,839 | 50.00% | 0.02% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | M | Common Stock | 3928 | $0.00 | 94,526.0000 | 20,333,839 | 4.34% | 0.02% |
| Dec. 19, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | F | Common Stock | 1153 | $13.51 | 93,373.0000 | 20,333,839 | 1.22% | 0.01% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | F | Common Stock | 1952 | $18.75 | 90,598.0000 | 20,333,839 | 2.11% | 0.01% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | M | Restricted Stock Units | 6649 | $0.00 | 0.0000 | 20,333,839 | 100.00% | 0.03% |
| Oct. 3, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | M | Common Stock | 6649 | $0.00 | 92,550.0000 | 20,333,839 | 7.74% | 0.03% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | A | Common Stock | 15625 | $0.00 | 85,901.0000 | 20,297,388 | 22.23% | 0.08% |
| Aug. 21, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal & Admin Officer | A | Stock Option | 35156 | $0.00 | 35,156.0000 | 20,297,388 | 9999.99% | 0.17% |
| March 1, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal Officer & CHRO | F | Common Stock | 268 | $5.18 | 70,276.0000 | 20,194,697 | 0.38% | 0.00% |
| March 1, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal Officer & CHRO | M | Common Stock | 771 | $0.00 | 70,544.0000 | 20,194,697 | 1.11% | 0.00% |
| March 1, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal Officer & CHRO | M | Restricted Stock Units | 771 | $0.00 | 0.0000 | 20,194,697 | 100.00% | 0.00% |
| Feb. 15, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | Chief Legal Officer & CHRO | F | Common Stock | 1479 | $6.64 | 69,773.0000 | 20,194,697 | 2.08% | 0.01% |
| Feb. 11, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 4000 | $0.00 | 12,000.0000 | 20,194,697 | 25.00% | 0.02% |
| Feb. 11, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 4000 | $0.00 | 72,638.0000 | 20,194,697 | 5.83% | 0.02% |
| Feb. 11, 2025 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 1386 | $5.60 | 71,252.0000 | 20,194,697 | 1.91% | 0.01% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | A | Common Stock | 41408 | $0.00 | 68,638.0000 | 20,069,432 | 152.07% | 0.21% |
| Dec. 23, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | A | Stock Option | 77742 | $0.00 | 77,742.0000 | 20,069,432 | 9999.99% | 0.39% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 3927 | $0.00 | 7,856.0000 | 20,069,432 | 33.33% | 0.02% |
| Dec. 19, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 3927 | $0.00 | 28,383.0000 | 20,069,432 | 16.06% | 0.02% |
| Dec. 20, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 1153 | $4.75 | 27,230.0000 | 20,069,432 | 4.06% | 0.01% |
| Nov. 8, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 1785 | $0.00 | 24,980.0000 | 20,069,432 | 7.70% | 0.01% |
| Nov. 8, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 524 | $6.27 | 24,456.0000 | 20,069,432 | 2.10% | 0.00% |
| Nov. 8, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 1785 | $0.00 | 0.0000 | 20,069,432 | 100.00% | 0.01% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 1952 | $7.83 | 23,195.0000 | 20,069,432 | 7.76% | 0.01% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 6649 | $0.00 | 25,147.0000 | 20,069,432 | 35.94% | 0.03% |
| Oct. 3, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 6649 | $0.00 | 6,649.0000 | 20,069,432 | 50.00% | 0.03% |
| Feb. 15, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | A | Common Stock | 4267 | $0.00 | 18,498.0000 | 19,899,679 | 29.98% | 0.02% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 771 | $0.00 | 14,499.0000 | 19,899,679 | 5.62% | 0.00% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 268 | $15.95 | 14,231.0000 | 19,899,679 | 1.85% | 0.00% |
| March 1, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 771 | $0.00 | 771.0000 | 19,899,679 | 50.00% | 0.00% |
| Dec. 19, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | A | Stock Option | 11783 | $0.00 | 11,783.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | A | Restricted Stock Units | 11783 | $0.00 | 11,783.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 4000 | $0.00 | 16,000.0000 | 19,899,679 | 20.00% | 0.02% |
| Feb. 11, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 4000 | $0.00 | 15,114.0000 | 19,899,679 | 35.99% | 0.02% |
| Feb. 11, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 1386 | $15.39 | 13,728.0000 | 19,899,679 | 9.17% | 0.01% |
| Jan. 9, 2024 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | S | Common Stock | 4000 | $15.19 | 11,114.0000 | 19,899,679 | 26.47% | 0.02% |
| Nov. 8, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 524 | $9.21 | 15,114.0000 | 0 | 3.35% | 0.00% |
| Nov. 8, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 1785 | $0.00 | 1,785.0000 | 0 | 50.00% | 0.00% |
| Nov. 8, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 1785 | $0.00 | 15,638.0000 | 0 | 12.89% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 6649 | $0.00 | 13,298.0000 | 0 | 33.33% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 1952 | $7.06 | 13,853.0000 | 0 | 12.35% | 0.00% |
| Oct. 3, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 6649 | $0.00 | 15,805.0000 | 0 | 72.62% | 0.00% |
| March 1, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 771 | $0.00 | 1,542.0000 | 0 | 33.33% | 0.00% |
| March 1, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 268 | $18.11 | 9,156.0000 | 0 | 2.84% | 0.00% |
| March 1, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 771 | $0.00 | 9,424.0000 | 0 | 8.91% | 0.00% |
| Feb. 11, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Common Stock | 4000 | $0.00 | 10,075.0000 | 0 | 65.84% | 0.00% |
| Feb. 11, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | M | Restricted Stock Units | 4000 | $0.00 | 12,000.0000 | 0 | 25.00% | 0.00% |
| Feb. 11, 2023 | OptimizeRx Corp | $OPRX | Odence-Ford Marion | General Counsel and CCO | F | Common Stock | 1422 | $17.34 | 8,653.0000 | 0 | 14.11% | 0.00% |